Patent ID: 8637078

Claim:
A bilayer pharmaceutical tablet comprising: a first layer providing a dissolving matrix containing: 40 mg of telmisartan, 40 mg of meglumine, 8 mg of poloxamer 188, 80.5 mg of D-mannitol, 0.14 mg of iron oxide yellow, and 1.5 mg of magnesium stearate; and a second layer providing a disintegrating tablet matrix containing: 12.5 mg of hydrochlorothiazide, 43 mg of D-mannitol, 11 mg of crystalline cellulose, 3 mg of hydroxypropylcellulose, 0.07 mg of iron oxide yellow, and 0.5 mg of magnesium stearate; or a first layer providing a dissolving matrix containing: 80 mg of telmisartan, 80 mg of meglumine, 16 mg of poloxamer 188, 161 mg of D-mannitol, 0.28 mg of iron oxide yellow, and 3 mg of magnesium stearate; and a second layer providing a disintegrating tablet matrix containing: 12.5 mg of hydrochlorothiazide, 98.5 mg of D-mannitol, 22 mg of crystalline cellulose, 6 mg of hydroxypropylcellulose, 0.14 mg of iron oxide yellow, and 1 mg of magnesium stearate.